This report provides information on ongoing randomized controlled trials of intravenous immune globulin and hyperimmune globulin being investigated for the treatment of COVID-19. It will be updated every two weeks. Ongoing trials of convalescent plasma are addressed in separate CADTH reports.

Link to Report

Ongoing Trials of Plasma-Based Therapies for the Treatment of COVID-19 (Updated on July 9, 2020)

Provide Feedback

Was this site helpful?

If you couldn’t find what you are looking for, please submit a request.